COVID-19 can be considered a systemic disease characterized by the dysregulation of the immune system and a hypercoagulable status, a consequence of direct virus-induced endothelial damage, amplified by the leukocyte- and cytokine-mediated activation of the platelets, the release of TF, and NETosis and intensified by the activation of the complement system. Here, TF is linked to COVID-19.